Malcolm is a Lead Scientist at MDC with 20+ years of experience in diverse Drug Discovery projects for efficacy and safety targets working at Pfizer and AstraZeneca.
Malcolm has a PhD from the University of Leicester, followed by a postdoctoral position at the NIH in the USA studying HIV-1 pathogenesis. At MDC, his current role is the development of more predictive cell models by exploiting multi-cellular cultures, organ-on-a-chip technologies and leading-edge detection techniques.
